• 首頁> 新聞動態> 前海安測入選“深圳創新70強”

    前海安測入選“深圳創新70強”

    2019-10-09 15:19

    2019年10月9日,由時代商家雜志社、深圳商報&讀創和深圳市時代新經濟發展研究院共同發起、歷時6個多月的“深圳創新企業70強”評選活動正式公布榜單。榜單上既有華為、騰訊等世界500強,也有一批市場占有率位居全球或全國第一的“隱形冠軍”。易特科集團旗下的深圳市前海安測信息技術有限公司跟隨華為騰訊等巨頭排名第44名,這表明前海安測在智慧醫療領域的產品創新、技術創新和知識產權創新實力獲得組委會認可,創新實力在智慧醫療領域全國領先!


    深圳創新企業是深圳高新技術產業的脊梁,是深圳高質量發展的代名詞。組委會認為,入選“深圳創新企業70強”的深圳企業是創新驅動的佼佼者,是深圳建設先行示范區的產業先鋒,是深圳自主創新實力的一次集中展示。前海安測在本次“創新70強”名單中位列第44名,將充分發揮智慧醫療創新優勢,幫助廣大醫療機構完善各項醫療服務,助力改善國人健康,提高生命質量!


    深圳市前海安測信息技術有限公司深耕醫療大健康行業,以尖端技術研究和創新為公司核心發展戰略,持續投入信息技術、生物科技、數字技術等領域,以最先進的人工智能、大數據、深度學習等技術和產品服務于醫療信息化、健康養老行業,現已成長為全國智慧醫療領軍企業、國家首批智慧健康養老應用試點示范企業和工信部醫療大數據產業發展試點示范企業。

    前海安測一貫堅持“技術進步、人才先行”政策,設立了院士工作站和博士后工作站,并與2名諾獎科學家、5名中外院士、20名教授建立了長期的合作關系。

    前海安測產品創新主要體現在如下三個方面:

    1、老齡化加劇和慢病劇增必然會導致慢病管理和服務需求的同步增長,而慢病群體“日常監測、及時評估、長期干預”的疾病特征使其有別于目前的醫療服務模式,從而需要基層醫療服務模式進行同步改進。針對這一特殊需求,前海安測研發了安測慢病管理系統、安測健康管理系統和安測一體化智能檢測設備,可以同時兼顧居家監測和基層醫療服務需求。該產品已入選國家工信、民政、衛健委等三部委《2018智慧健康養老產品及服務推廣目錄并獲得2018年深圳市科技進步獎二等獎。產品已廣泛應用于全國650多家醫院和450多家社區醫療單位。

    2、為適應健康體檢“從疾病篩查向健康服務”發展趨勢,并解決檢前、檢中和檢后相脫節問題,前海安測研發了集“檢前預約、檢中導檢、智能總檢、檢后隨訪、慢病管理、中醫治未病干預”的“安測全流程智慧健康體檢系統”,創新引入微服務云架構模式,支持醫聯體和縣市區域內體檢業務的蓬勃開展。

    3、針對醫院床位緊缺和家庭病床模式的興起,前海安測推出了“安測家庭病床與互聯網護理系統”,對出院后患者實施“醫院-社區-家庭”三元聯動延續護理服務,為患者、社區護士、臨床專家提供全場景的受理評估、信息采集、質量監控、移動問診等技術支持與硬件保障。

    在技術創新方面,前海安測針對慢性病、常見病、多發病等互聯網醫療的現實需求,在生物信息、生物傳感器、監測設備、影像診斷、醫療信息化、醫療云計算、數據挖掘、深度學習、輔助診斷等領域,已申請/擁有各類知識產權3100多項,在智慧醫療細分領域國內第一、全球第四,獲得4項國家專利優秀獎,是國家、廣東省和深圳市知識產權優勢企業、廣東省知識產權示范企業。


    Qianhai AnyCheck was selected as "Shenzhen Innovation Top 70"

    On October 9th, 2019, the "Shenzhen Innovative Enterprise Top 70" selection campaign was officially announced by Times Business Magazine, Shenzhen Commercial Daily & Reader and Shenzhen Times New Economic Development Research Institute. The list includes Huawei, Tencent and other Fortune 500 companies, as well as a number of “invisible champions” with market share ranking first in the world or in the country. Shenzhen Qianhai AnyCheck Information Technology Co., Ltd., a subsidiary of E-Techco Group, followed the giants such as Huawei and Tencent, ranking 44th. This shows that Qianhai AnyCheck's product innovation, technological innovation and intellectual property innovation strength in the field of smart medical care have been recognized by the organizing committee. The innovation strength is leading in the field of smart medical field.

    Shenzhen Innovative Enterprise is the backbone of Shenzhen's high-tech industry and is synonymous with high-quality development in Shenzhen. The organizing committee believes that the Shenzhen enterprise selected as one of the “Top 70 Innovative Enterprises in Shenzhen” is the leader of innovation drive, the industry pioneer of Shenzhen's pioneering demonstration zone, and a concentrated display of Shenzhen's independent innovation strength. Qianhai AnyCheck ranked 44th in the list of “Top 70 Innovations”, which will give full play to the advantages of smart medical innovation, help medical institutions improve various medical services, help improve the health of Chinese people and improve the quality of life.

    Shenzhen Qianhai AnyCheck Information Technology Co., Ltd. is deeply rooted in the medical and health industry. With cutting-edge technology research and innovation as its core development strategy, it continues to invest in information technology, biotechnology, digital technology and other fields, with the most advanced artificial intelligence, big data, deep learning and other technologies and products serve the medical informationization and health care industry. Now it has grown into a national smart medical leading enterprise, the country's first batch of smart health pension application pilot demonstration enterprises and the Ministry of Industry and Information Technology medical big data industry development pilot model enterprises.

    Qianhai AnyCheck has consistently adhered to the policy of “Technology Progress, Talent First”, established academician workstations and postdoctoral workstations, and established long-term cooperative relationships with two Nobel Prize scientists, five Chinese and foreign academicians, and 20 professors.

    Qianhai's product innovation is mainly reflected in the following three aspects:

    1. Increased aging and a sharp increase in chronic diseases will inevitably lead to the simultaneous growth of chronic disease management and service demand, while the disease characteristics of 'temporal monitoring, timely assessment, long-term intervention' of chronic disease groups make it different from current medical service models. Therefore, the primary medical service model needs to be synchronized and improved. In response to this special demand, Qianhai AnyCheck has developed AnyCheck Chronic Disease Management System and the integrated testing and testing equipment for security testing, which can simultaneously meet the needs of home monitoring and primary medical services. The product has been selected into the National Engineering Letter, Civil Affairs, Health and Welfare Committee and other three ministries ‘2018 Smart Health Elderly Care Products and Services Promotion Catalogue’ and won the second prize of Shenzhen Science and Technology Progress Award in 2018.

    2. In order to adapt to the development trend of 'health screening to health service' for health checkup and to solve the problem of dissociation before, during and after the inspection, Qianhai AnyCheck has developed a set of pre-inspection, pre-inspection and post-inspection interventions. Comprehensive health check-up system for the security area.

    3. In response to the shortage of hospital beds and the rise of the family bed model, Qianhai AnyCheck has launched an ambulatory family bed solution. At present, Qianhai AnyCheck's self-developed products and solutions have been widely used in more than 650 hospitals and more than 450 community medical units nationwide.

    In terms of technological innovation, Qianhai AnyCheck is aimed at the real needs of Internet medical treatment such as chronic diseases, common diseases and frequently-occurring diseases, in biological information, biosensors, monitoring equipment, image diagnosis, medical informationization, medical cloud computing, data mining, deep learning. In the field of auxiliary diagnosis, it has applied for/owned more than 3,100 kinds of intellectual property rights, ranking first in the field of smart medical treatment and fourth in the world, and won four national patent excellence awards. It is the intellectual property advantage of the country, Guangdong province and Shenzhen Enterprises, Guangdong province intellectual property model enterprises.


    按年份查詢

    全部

    2021

    2020

    2019

    2018

    2017

    2016

    2015

    2014

    2013

    搜索

    在线彩票购买 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>